nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—NR3C2—Preimplantation Embryo—TBX3—ocular cancer	0.0782	0.0782	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Preimplantation Embryo—E2F5—ocular cancer	0.0553	0.0553	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNA11—ocular cancer	0.029	0.029	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—ADP signalling through P2Y purinoceptor 1—GNAQ—ocular cancer	0.0269	0.0269	CbGpPWpGaD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—CCND2—ocular cancer	0.0244	0.0244	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signal amplification—GNA11—ocular cancer	0.0244	0.0244	CbGpPWpGaD
Fluticasone Propionate—NR3C2—ACE Inhibitor Pathway—TGFB1—ocular cancer	0.023	0.023	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signal amplification—GNAQ—ocular cancer	0.0227	0.0227	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CRTC1—ocular cancer	0.0201	0.0201	CbGpPWpGaD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—CDK4—ocular cancer	0.0164	0.0164	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—E2F5—ocular cancer	0.0149	0.0149	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—E2F4—ocular cancer	0.0146	0.0146	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RBL1—ocular cancer	0.0143	0.0143	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—HDAC1—ocular cancer	0.014	0.014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—GNA11—ocular cancer	0.0138	0.0138	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—GNAQ—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RBBP4—ocular cancer	0.0124	0.0124	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—TFDP1—ocular cancer	0.0115	0.0115	CbGpPWpGaD
Fluticasone Propionate—PGR—Ovarian Infertility Genes—CDKN1B—ocular cancer	0.0111	0.0111	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—E2F5—ocular cancer	0.0106	0.0106	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0104	0.0104	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—E2F4—ocular cancer	0.0104	0.0104	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—RBL1—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—E2F4—ocular cancer	0.01	0.01	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—RBL1—ocular cancer	0.00981	0.00981	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.00941	0.00941	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—RBL2—ocular cancer	0.009	0.009	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—SF3B1—ocular cancer	0.0087	0.0087	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—TFDP1—ocular cancer	0.0082	0.0082	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC1—ocular cancer	0.0067	0.0067	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—HDAC1—ocular cancer	0.00664	0.00664	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—MYC—ocular cancer	0.00659	0.00659	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MAML2—ocular cancer	0.00651	0.00651	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—E2F5—ocular cancer	0.00645	0.00645	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—E2F4—ocular cancer	0.00632	0.00632	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—RBL1—ocular cancer	0.0062	0.0062	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—EIF1AX—ocular cancer	0.00613	0.00613	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.00607	0.00607	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—ocular cancer	0.00601	0.00601	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.00558	0.00558	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SF3B1—ocular cancer	0.0053	0.0053	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00529	0.00529	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—p38 MAPK Signaling Pathway—HRAS—ocular cancer	0.00518	0.00518	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—E2F5—ocular cancer	0.0051	0.0051	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—GNA11—ocular cancer	0.00507	0.00507	CbGpPWpGaD
Fluticasone Propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—ocular cancer	0.005	0.005	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—E2F4—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00499	0.00499	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—RPL39—ocular cancer	0.0049	0.0049	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—RBL1—ocular cancer	0.0049	0.0049	CbGpPWpGaD
Fluticasone Propionate—PGR—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.00487	0.00487	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—HDAC1—ocular cancer	0.00476	0.00476	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00476	0.00476	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—GNAQ—ocular cancer	0.00471	0.00471	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00468	0.00468	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGF Pathway—HRAS—ocular cancer	0.00464	0.00464	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.0045	0.0045	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00428	0.00428	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00427	0.00427	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—RBBP4—ocular cancer	0.00425	0.00425	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—HDAC1—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MAML2—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—TFDP1—ocular cancer	0.00395	0.00395	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00392	0.00392	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—E2F1—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00375	0.00375	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—EIF1AX—ocular cancer	0.00373	0.00373	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—E2F5—ocular cancer	0.00373	0.00373	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—E2F4—ocular cancer	0.00365	0.00365	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Circadian Clock—EP300—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—RBL1—ocular cancer	0.00358	0.00358	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—MDM2—ocular cancer	0.00349	0.00349	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00342	0.00342	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00339	0.00339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PSPH—ocular cancer	0.00336	0.00336	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—ocular cancer	0.0033	0.0033	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—CCND1—ocular cancer	0.00326	0.00326	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—ocular cancer	0.00324	0.00324	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.0032	0.0032	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—CDKN1B—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—HRAS—ocular cancer	0.00316	0.00316	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MAML2—ocular cancer	0.00314	0.00314	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—E2F5—ocular cancer	0.0031	0.0031	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SF3B1—ocular cancer	0.00306	0.00306	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—E2F4—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—EP300—ocular cancer	0.003	0.003	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—RPL39—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—RBL1—ocular cancer	0.00298	0.00298	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—CDKN1A—ocular cancer	0.00294	0.00294	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—HDAC1—ocular cancer	0.0029	0.0029	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—TFDP1—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—ocular cancer	0.00286	0.00286	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00281	0.00281	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Endothelins—AKT1—ocular cancer	0.00279	0.00279	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—ocular cancer	0.00278	0.00278	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—AGE/RAGE pathway—AKT1—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—RB1—ocular cancer	0.00268	0.00268	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00267	0.00267	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Endoderm Differentiation—TGFB1—ocular cancer	0.00267	0.00267	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Fluticasone Propionate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—ocular cancer	0.00263	0.00263	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—MYC—ocular cancer	0.00262	0.00262	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TGFB1—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—GNA11—ocular cancer	0.00261	0.00261	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.0026	0.0026	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—RBBP4—ocular cancer	0.00259	0.00259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—GNAQ—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—TFDP1—ocular cancer	0.0024	0.0024	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00237	0.00237	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PSPH—ocular cancer	0.00234	0.00234	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—MYC—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MAML2—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—HDAC1—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SAG—ocular cancer	0.00228	0.00228	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HDAC1—ocular cancer	0.00219	0.00219	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00217	0.00217	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—EIF1AX—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Fluticasone Propionate—NR3C1—AP-1 transcription factor network—TP53—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00207	0.00207	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—CDKN2B—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—E2F5—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.002	0.002	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—E2F4—ocular cancer	0.00198	0.00198	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RBL1—ocular cancer	0.00194	0.00194	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—CDKN1A—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—HRAS—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MAML2—ocular cancer	0.00191	0.00191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.0019	0.0019	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—ocular cancer	0.00189	0.00189	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SAG—ocular cancer	0.00186	0.00186	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—E2F5—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—E2F4—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RBL1—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RPL39—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSPH—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling by ERBB4—AKT1—ocular cancer	0.00169	0.00169	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—E2F3—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—HDAC1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Generic Transcription Pathway—MYC—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—E2F5—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—E2F4—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TGFB1—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RBL1—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TFDP1—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—CDK2—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GNA11—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—RBBP4—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—HDAC1—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GNAQ—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—TFDP1—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—E2F3—ocular cancer	0.00137	0.00137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TFDP1—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—CDKN2B—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MAML2—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MAML2—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GNA11—ocular cancer	0.00108	0.00108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GNA11—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.00102	0.00102	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MAML2—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GNAQ—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GNAQ—ocular cancer	0.000984	0.000984	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HDAC1—ocular cancer	0.000908	0.000908	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNA11—ocular cancer	0.000885	0.000885	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—EP300—ocular cancer	0.000872	0.000872	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNAQ—ocular cancer	0.000823	0.000823	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN2B—ocular cancer	0.000814	0.000814	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HDAC1—ocular cancer	0.000807	0.000807	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—ocular cancer	0.000797	0.000797	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000794	0.000794	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSPH—ocular cancer	0.000788	0.000788	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—ocular cancer	0.000758	0.000758	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—E2F1—ocular cancer	0.000747	0.000747	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HDAC1—ocular cancer	0.000742	0.000742	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNA11—ocular cancer	0.000738	0.000738	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—CDKN2B—ocular cancer	0.000724	0.000724	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNAQ—ocular cancer	0.000686	0.000686	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—ocular cancer	0.000665	0.000665	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—ocular cancer	0.000624	0.000624	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—E2F1—ocular cancer	0.00061	0.00061	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—ocular cancer	0.000597	0.000597	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—ocular cancer	0.000582	0.000582	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—ocular cancer	0.000552	0.000552	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNA11—ocular cancer	0.000533	0.000533	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—ocular cancer	0.000527	0.000527	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNAQ—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—ocular cancer	0.000485	0.000485	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MDM2—ocular cancer	0.000452	0.000452	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1B—ocular cancer	0.000412	0.000412	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—ocular cancer	0.000393	0.000393	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CDKN1A—ocular cancer	0.00038	0.00038	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MDM2—ocular cancer	0.000369	0.000369	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EP300—ocular cancer	0.000362	0.000362	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—EP300—ocular cancer	0.000354	0.000354	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1B—ocular cancer	0.000337	0.000337	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—ocular cancer	0.000321	0.000321	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN1A—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—ocular cancer	0.000303	0.000303	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EP300—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—ocular cancer	0.000258	0.000258	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNA11—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—ocular cancer	0.000248	0.000248	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—EP300—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNAQ—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—ocular cancer	0.000219	0.000219	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—ocular cancer	0.000202	0.000202	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—EP300—ocular cancer	0.000178	0.000178	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—ocular cancer	0.000149	0.000149	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—ocular cancer	0.000108	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—EP300—ocular cancer	8.28e-05	8.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—ocular cancer	5.01e-05	5.01e-05	CbGpPWpGaD
